Home › Compare › ASLN vs VICI

ASLN vs VICI: Dividend Comparison 2026

ASLN yields 333.33% · VICI yields 6.57%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ASLN wins by $3111.26M in total portfolio value
10 years
ASLN
ASLN
● Live price
333.33%
Share price
$0.60
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3112.25M
Annual income
$1,957,209,378.70
Full ASLN calculator →
VICI
VICI Properties Inc.
● Live price
6.57%
Share price
$27.12
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$988.8K
Annual income
$623,261.32
Full VICI calculator →

Portfolio growth — ASLN vs VICI

📍 ASLN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodASLNVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ASLN + VICI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
ASLN pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ASLN
Annual income on $10K today (after 15% tax)
$28,333.33/yr
After 10yr DRIP, annual income (after tax)
$1,663,627,971.90/yr
VICI
Annual income on $10K today (after 15% tax)
$558.67/yr
After 10yr DRIP, annual income (after tax)
$529,772.12/yr
At 15% tax rate, ASLN beats the other by $1,663,098,199.77/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ASLN + VICI for your $10,000?

ASLN: 50%VICI: 50%
100% VICI50/50100% ASLN
Portfolio after 10yr
$1556.62M
Annual income
$978,916,320.01/yr
Blended yield
62.89%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

ASLN
No analyst data
Altman Z
-14.9
Piotroski
3/9
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+16.5% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ASLN buys
0
VICI buys
0
No recent congressional trades found for ASLN or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricASLNVICI
Forward yield333.33% ✓6.57%
Annual dividend / share$2.00 ✓$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%44.3% ✓
Portfolio after 10y$3112.25M ✓$988.8K
Annual income after 10y$1,957,209,378.70 ✓$623,261.32
Total dividends collected$3000.20M ✓$948.4K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: ASLN vs VICI ($10,000, DRIP)

YearASLN PortfolioASLN Income/yrVICI PortfolioVICI Income/yrGap
1← crossover$44,033$33,333.33$11,368$948.43+$32.7K → ASLN
2$184,291$137,175.49$13,339$1,493.16+$171.0K → ASLN
3$733,748$536,556.79$16,326$2,426.21+$717.4K → ASLN
4$2,781,635$1,996,524.01$21,123$4,112.15+$2.76M → ASLN
5$10,050,002$7,073,652.70$29,379$7,368.23+$10.02M → ASLN
6$34,638,543$23,885,041.43$44,804$14,191.64+$34.59M → ASLN
7$114,000,322$76,937,080.16$76,658$29,972.12+$113.92M → ASLN
8$358,625,914$236,645,569.53$150,894$71,015.81+$358.48M → ASLN
9$1,079,474,884$695,745,156.26$350,814$193,582.47+$1079.12M → ASLN
10$3,112,247,504$1,957,209,378.70$988,809$623,261.32+$3111.26M → ASLN

ASLN vs VICI: Complete Analysis 2026

ASLN — Stock

ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase for the treatment of autoimmune conditions. It has a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd. to develop immuno-oncology therapeutics for markets targeting the AhR pathway. Its partners include Almirall, Array BioPharma, and CSL Limited. The company was founded in 2010 and is headquartered in Singapore.

Full ASLN Calculator →

VICI — REIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this ASLN vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ASLN vs SCHDASLN vs JEPIASLN vs OASLN vs KOASLN vs MAINASLN vs NNNASLN vs EPRTASLN vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.